ANEBULO PHARMACEUTICALS, INC. Current Liabilities
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Current Liabilities of $293.17 thousand as of 2021-03-31, per its 10-Q filed 2021-06-21.
Discontinued › Balance Sheet
us-gaap:LiabilitiesCurrent · last filed 2021-06-21
- 2021-03-31: Liabilities, Current $293.17K.
- 2020-06-30: Liabilities, Current $223.87K.
| Period end | Liabilities, Current |
|---|---|
| 2021-03-31 | $293.17K 10-Q · filed 2021-06-21 |
| 2020-06-30 | $223.87K 10-Q · filed 2021-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |